The Indonesian regulation for clinical research has shown a significant transformation during the past year, after practically being at a very low level for the past decade. The Ministry of Health, together with the Indonesian Drug and Food Regulatory Body are prepared to welcome global pharmaceutical companies to conduct researches in various hospitals in the country.
Learning Objectives
Analyze the recent transformations in Indonesian clinical research regulations and their impact on the country's research environment; Evaluate the opportunities and challenges for global pharmaceutical companies conducting clinical research in Indonesia under the new regulatory framework.
